Coronary endothelial dysfunction prevented by small-conductance calcium-activated potassium channel activator in mice

Zhiqi Zhang1, Guangbin Shi1, Yuhong Liu1

  • 1Division of Cardiothoracic Surgery, Rhode Island Hospital, Providence, RI.

Abstract

Insights

A small-conductance calcium-activated potassium (SK) channel activator, NS309, protects coronary microvasculature from cardioplegic-hypoxia and reoxygenation (CP-H/R) injury. However, this protective effect is reduced in diabetic patients and mice.

Area of Science:

  • Cardiovascular Science
  • Endothelial Biology
  • Potassium Channel Function

Background:

  • Coronary microvascular dysfunction is a significant complication following cardiac procedures.
  • Small-conductance calcium-activated potassium (SK) channels play a role in regulating vascular tone and endothelial function.
  • Diabetes mellitus exacerbates cardiovascular injury and impairs endothelial function.

Purpose of the Study:

  • To evaluate the protective effects of an SK channel activator against cardioplegic-hypoxia and reoxygenation (CP-H/R) injury.
  • To compare the efficacy of SK channel activation in diabetic versus nondiabetic subjects.
  • To investigate the impact of CP-H/R on SK channel function and expression in the coronary microvasculature.

Main Methods:

  • Mouse and human coronary endothelial cells and small arteries were isolated.
  • Cells and vessels were subjected to in vitro CP-H/R injury.
  • Treatment with the selective SK channel activator NS309 was administered before and during CP-H/R.
  • SK current density, coronary relaxation, and SK3 channel expression were measured.

Main Results:

  • CP-H/R injury significantly reduced SK current density and coronary relaxation responses.
  • NS309 treatment significantly improved endothelial function recovery after CP-H/R.
  • The protective effect of NS309 was more pronounced in nondiabetic subjects compared to diabetic subjects.
  • Hypoxia led to reduced cell surface SK3 expression and increased cytosolic SK3 expression.

Conclusions:

  • The SK channel activator NS309 demonstrates protective effects on the coronary microvasculature against CP-H/R injury.
  • Diabetic coronary microvasculature exhibits a diminished response to NS309-mediated protection.
  • SK channel dysfunction, including altered expression and localization, may contribute to CP-H/R-induced vascular dysfunction in diabetes.

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
537
Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
1.4K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
789
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
297
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
1.9K
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
182